Dietary (n-3) polyunsaturated fatty acids affect the kinetics of pro- and antiinflammatory responses in mice with Pseudomonas aeruginosa lung infection.
暂无分享,去创建一个
F. Gottrand | B. Guery | C. Galabert | C. Beermann | J. Desseyn | M. Pierre | M. Husson | H. Tiesset
[1] P. Calder. Immunomodulation by omega-3 fatty acids. , 2007, Prostaglandins, leukotrienes, and essential fatty acids.
[2] S. Sert,et al. Liver lipid peroxidation in experimental Escherichia coli peritonitis: the role of myeloperoxidase and nitric oxide inhibition. , 2007, Medical science monitor : international medical journal of experimental and clinical research.
[3] C. Glass,et al. PPARs and molecular mechanisms of transrepression. , 2007, Biochimica et biophysica acta.
[4] F. Gottrand,et al. Dietary n-3 fatty acids have suppressive effects on mucin upregulation in mice infected with Pseudomonas aeruginosa , 2007, Respiratory research.
[5] H. Bujo,et al. Effect of PPARalpha activation of macrophages on the secretion of inflammatory cytokines in cultured adipocytes. , 2007, European journal of pharmacology.
[6] H. Roche,et al. Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid. , 2007, The Journal of nutritional biochemistry.
[7] F. Gottrand,et al. Omega-3 polyunsaturated fatty acids improve host response in chronic Pseudomonas aeruginosa lung infection in mice. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[8] B. Brüne,et al. Peroxisome proliferator-activated receptor γ (PPARγ) and sepsis , 2007, Archivum Immunologiae et Therapiae Experimentalis.
[9] S. Akira,et al. The myeloid differentiation factor 88 is dispensable for the development of a delayed host response to Pseudomonas aeruginosa lung infection in mice , 2006, Clinical and experimental immunology.
[10] A. Simopoulos. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. , 2006, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[11] C. Ferran,et al. A20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasia , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[12] T. Buclin,et al. Biological effects of a dietary omega-3 polyunsaturated fatty acids supplementation in cystic fibrosis patients: a randomized, crossover placebo-controlled trial. , 2006, Clinical nutrition.
[13] P. Calder. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. , 2006, The American journal of clinical nutrition.
[14] E. Mazzon,et al. The role of the peroxisome proliferator‐activated receptor‐α (PPAR‐α) in the regulation of acute inflammation , 2006 .
[15] F. Gottrand,et al. Long-Chain Polyunsaturated Fatty Acids Modulate Lung Inflammatory Response Induced by Pseudomonas aeruginosa in Mice , 2005, Pediatric Research.
[16] Richard A. Young,et al. Insights into host responses against pathogens from transcriptional profiling , 2005, Nature Reviews Microbiology.
[17] Z. Varghese,et al. EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism. , 2005, Kidney international.
[18] R. Chapkin,et al. Dietary Docosahexaenoic Acid Suppresses T Cell Protein Kinase Cθ Lipid Raft Recruitment and IL-2 Production1 , 2004, The Journal of Immunology.
[19] C. Pham,et al. NF-κB and JNK: An Intricate Affair , 2004 .
[20] K. Leslie,et al. Identification of a novel mechanism of NF-kappaB inactivation by progesterone through progesterone receptors in Hec50co poorly differentiated endometrial cancer cells: induction of A20 and ABIN-2. , 2004, Gynecologic oncology.
[21] J. Goust,et al. The Effects of Calpain Inhibition on IkBα Degradation After Activation of PBMCs: Identification of the Calpain Cleavage Sites , 2004, Neurochemical Research.
[22] V. Keshamouni,et al. Deactivation of murine alveolar macrophages by peroxisome proliferator-activated receptor-gamma ligands. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[23] M. De la Fuente,et al. Immune cells: free radicals and antioxidants in sepsis. , 2004, International immunopharmacology.
[24] S. Wassall,et al. Docosahexaenoic acid: membrane properties of a unique fatty acid. , 2003, Chemistry and physics of lipids.
[25] N. Sizemore,et al. Reciprocal Modulation of Toll-like Receptor-4 Signaling Pathways Involving MyD88 and Phosphatidylinositol 3-Kinase/AKT by Saturated and Polyunsaturated Fatty Acids* , 2003, Journal of Biological Chemistry.
[26] V. Cherezov,et al. Interaction of cholesterol with a docosahexaenoic acid-containing phosphatidylethanolamine: trigger for microdomain/raft formation? , 2003, Biochemistry.
[27] R. Chapkin,et al. Dietary (n-3) polyunsaturated fatty acids remodel mouse T-cell lipid rafts. , 2003, The Journal of nutrition.
[28] D. Hwang,et al. Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. , 2003, Journal of lipid research.
[29] A. Simopoulos. Omega-3 Fatty Acids in Inflammation and Autoimmune Diseases , 2002, Journal of the American College of Nutrition.
[30] K. Fritsche,et al. (n-3) Fatty acids and infectious disease resistance. , 2002, The Journal of nutrition.
[31] J. Davies,et al. Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence. , 2002, Paediatric respiratory reviews.
[32] M. Laville,et al. Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma. , 2002, Obesity research.
[33] J. Morrow,et al. Characterization of LPS-induced lung inflammation in cftr-/- mice and the effect of docosahexaenoic acid. , 2002, Journal of applied physiology.
[34] P. Calder,et al. Fatty acids and lymphocyte functions , 2002, British Journal of Nutrition.
[35] W. Waldhäusl,et al. Polyunsaturated Eicosapentaenoic Acid Displaces Proteins from Membrane Rafts by Altering Raft Lipid Composition* , 2001, The Journal of Biological Chemistry.
[36] D. Wakefield,et al. The role of IL-1ß in the regulation of IL-8 and IL-6 in human corneal epithelial cells during Pseudomonas aeruginosa colonization , 2001, Current eye research.
[37] B. Staels,et al. Induction of IκBα Expression as a Mechanism Contributing to the Anti-inflammatory Activities of Peroxisome Proliferator-activated Receptor-α Activators* , 2000, The Journal of Biological Chemistry.
[38] P. G. Reeves. Components of the AIN-93 diets as improvements in the AIN-76A diet. , 1997, The Journal of nutrition.
[39] M. D. Leibowitz,et al. Molecular Cloning, Expression and Characterization of Human Peroxisome Proliferator Activated Receptors γ1 and γ2 , 1996 .
[40] J. Dipiro,et al. Interleukin-10 is associated with the development of sepsis in trauma patients. , 1996, The Journal of trauma.
[41] E. Collie-Duguid,et al. Inhibitory effect of fish oil N-3 polyunsaturated fatty acids on the expression of endothelial cell adhesion molecules. , 1996, Biochemical and biophysical research communications.
[42] D. Noonan,et al. Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators , 1994, The Journal of Steroid Biochemistry and Molecular Biology.
[43] R. Colvin,et al. Suppression of autoimmune disease by dietary n-3 fatty acids. , 1993, Journal of lipid research.
[44] O. Mcbride,et al. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. , 1993, Biochemistry.
[45] R. Chapkin,et al. 5-series peptido-leukotriene synthesis in mouse peritoneal macrophages: modulation by dietary n-3 fatty acids. , 1990, Biochemical and biophysical research communications.
[46] J. Alexander,et al. The effect of dietary fatty acids on response to Pseudomonas infection in burned mice. , 1990, The Journal of trauma.
[47] B. Brüne,et al. Peroxisome proliferator-activated receptor gamma (PPAR gamma) and sepsis. , 2007, Archivum immunologiae et therapiae experimentalis.
[48] E. Mazzon,et al. The role of the peroxisome proliferator-activated receptor-alpha (PPAR-alpha) in the regulation of acute inflammation. , 2006, Journal of leukocyte biology.
[49] L. Cleland,et al. Biological activity of prostaglandin E3 with regard to oedema formation in mice , 2005, Agents and Actions.
[50] C. Pham,et al. NF-kappaB and JNK: an intricate affair. , 2004, Cell cycle.
[51] B. Staels,et al. Induction of IkappaBalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators. , 2000, The Journal of biological chemistry.
[52] M. D. Leibowitz,et al. Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. , 1996, Biochemical and biophysical research communications.
[53] J. Kinsella,et al. In vivo formation of leukotriene E5 by murine peritoneal cells. , 1991, Prostaglandins.